Screener
Regeneron Pharmaceuticals REGN Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's asset turnover?
- Regeneron Pharmaceuticals (REGN) reported asset turnover of 0.4× in Q2 2026.
- How has Regeneron Pharmaceuticals's asset turnover changed year-over-year?
- Regeneron Pharmaceuticals's asset turnover increased by 1.6% year-over-year, from 0.4× to 0.4×.
- What is the long-term trend for Regeneron Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's asset turnover has grown at a -7.2% compound annual growth rate (CAGR), from 0.5× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Regeneron Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude